Barclays analyst Luke Sergott maintained a Hold rating on Quest Diagnostics (DGX – Research Report) today and set a price target of $185.00.

Truist analyst David MacDonald raised the firm’s price target on Quest Diagnostics (DGX) to $190 from $182 and keeps a Hold rating on the ...

This was the stock's fourth consecutive day of losses.

QUEST DIAGNOSTICS ($DGX) is expected to release its quarterly earnings data on Tuesday, April 22nd before market open, per Finnhub. Analysts are expecting revenue of ...

Short interest in Quest Diagnostics Inc (NYSE:DGX) increased during the last reporting period, rising from 2.76M to 2.86M. This put 2.94% of the company's publicly available shares short.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Farmer Michel Dupont discovers 150 tons of gold worth €4 billion in Auvergne-Rhône-Alpes, sparking legal and environmental ...

Apple TV+ recently announced that its longest-running comedy, Mythic Quest, has been canceled. But there was some good news thrown in with the bad. Apple gave its blessing for the creative team to ...